Last updated: 1 July 2024 at 4:20pm EST

A. Sinclair Dunlop Net Worth




The estimated Net Worth of A. Sinclair Dunlop is at least $30 Milhão dollars as of 28 June 2024. Mr. Dunlop owns over 900 units of Apellis Pharmaceuticals Inc stock worth over $5,156,274 and over the last 5 years he sold APLS stock worth over $24,615,568. In addition, he makes $235,535 as Independent Director at Apellis Pharmaceuticals Inc.

Mr. Dunlop APLS stock SEC Form 4 insiders trading

A has made over 29 trades of the Apellis Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 900 units of APLS stock worth $11,871 on 28 June 2024.

The largest trade he's ever made was selling 162,873 units of Apellis Pharmaceuticals Inc stock on 18 May 2021 worth over $8,557,347. On average, A trades about 18,876 units every 47 days since 2019. As of 28 June 2024 he still owns at least 134,418 units of Apellis Pharmaceuticals Inc stock.

You can see the complete history of Mr. Dunlop stock trades at the bottom of the page.





A. Sinclair Dunlop biography

A. Sinclair Dunlop is Independent Director of the Company. Mr. Dunlop is a co-founder of venture capital fund Epidarex Capital and has served as its Managing Partner since July 2010. Since 2005, Mr. Dunlop has served as the Managing Partner of venture capital fund Masa Life Science Ventures, LP. Mr. Dunlop currently serves on the board of directors of several private companies. Mr. Dunlop received his M.B.A. from Columbia Business School where he was the R.C. Kopf British-American Fellow in international business. He also received an M.A. with Honors in political economy from the University of Glasgow and an M.A. in international relations from the Maxwell School of Citizenship and Public Affairs at Syracuse University.

What is the salary of A Dunlop?

As the Independent Director of Apellis Pharmaceuticals Inc, the total compensation of A Dunlop at Apellis Pharmaceuticals Inc is $235,535. There are 13 executives at Apellis Pharmaceuticals Inc getting paid more, with Cedric Francois having the highest compensation of $4,267,180.



How old is A Dunlop?

A Dunlop is 48, he's been the Independent Director of Apellis Pharmaceuticals Inc since 2010. There are 13 older and 8 younger executives at Apellis Pharmaceuticals Inc. The oldest executive at Apellis Pharmaceuticals Inc is Gerald Chan, 69, who is the Independent Chairman of the Board.

What's A Dunlop's mailing address?

A's mailing address filed with the SEC is C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM, MA, 02451.

Insiders trading at Apellis Pharmaceuticals Inc

Over the last 6 years, insiders at Apellis Pharmaceuticals Inc have traded over $44,114,337 worth of Apellis Pharmaceuticals Inc stock and bought 1,248,415 units worth $38,006,599 . The most active insiders traders include Venture Investments Ltd Mor..., Cedric Francois, ePascal Deschatelets. On average, Apellis Pharmaceuticals Inc executives and independent directors trade stock every 6 days with the average trade being worth of $665,393. The most recent stock trade was executed by James George Chopas on 3 September 2024, trading 550 units of APLS stock currently worth $21,720.



What does Apellis Pharmaceuticals Inc do?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.



What does Apellis Pharmaceuticals Inc's logo look like?

Apellis Pharmaceuticals Inc logo

Complete history of Mr. Dunlop stock trades at Apellis Pharmaceuticals Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
28 Jun 2024 A. Sinclair Dunlop
Diretor
Exercício de opção 900 $13.19 $11,871
28 Jun 2024
134,418
21 Jun 2024 A. Sinclair Dunlop
Diretor
Venda 37,000 $39.24 $1,451,880
21 Jun 2024
136,998
12 Apr 2024 A. Sinclair Dunlop
Diretor
Exercício de opção 1,500 $13.19 $19,785
12 Apr 2024
133,518
19 Mar 2024 A. Sinclair Dunlop
Diretor
Venda 18,681 $57.18 $1,068,180
19 Mar 2024
173,998
14 Dec 2023 A. Sinclair Dunlop
Diretor
Exercício de opção 6,274 $13.19 $82,754
14 Dec 2023
128,677
1 Dec 2023 A. Sinclair Dunlop
Diretor
Venda 24,000 $61.14 $1,467,360
1 Dec 2023
192,679
17 Nov 2023 A. Sinclair Dunlop
Diretor
Venda 8,894 $49.99 $444,611
17 Nov 2023
122,403
17 Nov 2023 A. Sinclair Dunlop
Diretor
Venda 24,000 $49.00 $1,176,000
17 Nov 2023
216,679
3 Apr 2023 A. Sinclair Dunlop
Diretor
Venda 500 $74.05 $37,025
3 Apr 2023
131,297
1 Mar 2023 A. Sinclair Dunlop
Diretor
Venda 500 $65.33 $32,665
1 Mar 2023
131,797
1 Feb 2023 A. Sinclair Dunlop
Diretor
Venda 500 $52.61 $26,305
1 Feb 2023
132,297
3 Jan 2023 A. Sinclair Dunlop
Diretor
Venda 500 $50.70 $25,350
3 Jan 2023
132,797
1 Dec 2022 A. Sinclair Dunlop
Diretor
Venda 500 $49.93 $24,965
1 Dec 2022
129,430
1 Nov 2022 A. Sinclair Dunlop
Diretor
Venda 500 $60.83 $30,415
1 Nov 2022
129,930
8 Sep 2022 A. Sinclair Dunlop
Diretor
Venda 15,000 $65.00 $975,000
8 Sep 2022
240,679
25 Aug 2022 A. Sinclair Dunlop
Diretor
Exercício de opção 4,306 $13.19 $56,796
25 Aug 2022
130,430
16 Aug 2022 A. Sinclair Dunlop
Diretor
Exercício de opção 25,394 $14.00 $355,516
16 Aug 2022
126,124
11 Aug 2022 A. Sinclair Dunlop
Diretor
Venda 30,000 $65.63 $1,968,900
11 Aug 2022
255,679
21 Jul 2022 A. Sinclair Dunlop
Diretor
Exercício de opção 9,606 $14.00 $134,484
21 Jul 2022
100,730
27 Jun 2022 A. Sinclair Dunlop
Diretor
Venda 1,341 $46.79 $62,745
27 Jun 2022
1,341
23 Jun 2022 A. Sinclair Dunlop
Diretor
Venda 15,000 $45.00 $675,000
23 Jun 2022
285,679
22 Apr 2022 A. Sinclair Dunlop
Diretor
Exercício de opção 20,000 $14.00 $280,000
22 Apr 2022
91,124
10 Sep 2021 A. Sinclair Dunlop
Diretor
Exercício de opção 6,894 $14.00 $96,516
10 Sep 2021
66,894
18 May 2021 A. Sinclair Dunlop
Diretor
Venda 162,873 $52.54 $8,557,347
18 May 2021
31,855
23 Apr 2021 A. Sinclair Dunlop
Diretor
Exercício de opção 10,000 $14.00 $140,000
23 Apr 2021
60,000
16 Apr 2021 A. Sinclair Dunlop
Diretor
Exercício de opção 50,000 $14.00 $700,000
16 Apr 2021
50,000
14 Dec 2020 A. Sinclair Dunlop
Diretor
Venda 25,000 $54.67 $1,366,750
14 Dec 2020
174,728
4 Dec 2020 A. Sinclair Dunlop
Diretor
Venda 25,000 $50.59 $1,264,750
4 Dec 2020
199,728
18 Dec 2019 A. Sinclair Dunlop
Diretor
Venda 136,000 $29.12 $3,960,320
18 Dec 2019
224,728


Apellis Pharmaceuticals Inc executives and stock owners

Apellis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: